Imunon, Inc. Earnings Per Share (Basic)
Imunon, Inc. (IMNN) reported Earnings Per Share (Basic) of -$0.54 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- Imunon, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.54.
- Imunon, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.84.
- Imunon, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$1.16.
- Imunon, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$2.15.
- Imunon, Inc. earnings per share, basic for fiscal 2025 was -$6.83.
- Imunon, Inc. earnings per share, basic for fiscal 2024 was -$16.94.
- Imunon, Inc. earnings per share, basic for fiscal 2023 was -$2.16.
- Imunon, Inc. earnings per share, basic for fiscal 2022 was -$5.03.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.54 10-Q · filed 2026-08-11 | -$1.38 10-Q · filed 2026-08-11 | ||||||
| 2026-03-31 | -$0.84 10-Q · filed 2026-05-12 | |||||||
| 2025-12-31 | -$6.83 10-K · filed 2026-03-31 | |||||||
| 2025-09-30 | -$1.16 10-Q · filed 2025-11-13 | -$5.53 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | -$2.15 10-Q · filed 2026-08-11 | -$6.08 10-Q · filed 2026-08-11 | ||||||
| 2025-03-31 | -$3.15 10-Q · filed 2026-05-12 | -$0.28 10-Q · filed 2025-05-12 | ||||||
| 2024-12-31 | -$16.94 10-K · filed 2026-03-31 | -$1.62 10-K · filed 2025-02-27 | ||||||
| 2024-09-30 | -$3.76 10-Q · filed 2025-11-13 | -$0.34 10-Q · filed 2024-11-07 | -$14.13 10-Q · filed 2025-11-13 | -$1.39 10-Q · filed 2024-11-07 | ||||
| 2024-06-30 | -$7.64 10-Q · filed 2025-08-05 | -$0.51 10-Q · filed 2024-08-14 | -$15.51 10-Q · filed 2025-08-05 | -$1.03 10-Q · filed 2024-08-14 | ||||
| 2024-03-31 | -$0.52 10-Q · filed 2025-05-12 | |||||||
| 2023-12-31 | -$2.16 10-K · filed 2025-02-27 | |||||||
| 2023-09-30 | -$0.37 10-Q · filed 2024-11-07 | -$1.64 10-Q · filed 2024-11-07 | ||||||
| 2023-06-30 | -$0.61 10-Q · filed 2024-08-14 | -$1.28 10-Q · filed 2024-08-14 | ||||||
| 2023-03-31 | -$0.68 10-Q · filed 2024-05-13 | |||||||
| 2022-12-31 | -$5.03 10-K · filed 2024-03-28 | |||||||
| 2022-09-30 | -$0.87 10-Q · filed 2023-11-14 | -$3.42 10-Q · filed 2023-11-14 | ||||||
| 2022-06-30 | -$0.87 10-Q · filed 2023-08-10 | -$2.59 10-Q · filed 2023-08-10 | ||||||
| 2022-03-31 | -$1.82 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | -$3.83 10-K · filed 2023-03-30 | |||||||
| 2021-09-30 | -$0.94 10-Q · filed 2022-11-14 | -$3.12 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$0.95 10-Q · filed 2022-08-15 | -$2.19 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | -$3.31 10-Q · filed 2022-05-16 | |||||||
| 2014-06-30 | -$0.38 derived: net income ÷ weighted average shares · filed 2015-08-10 | -$0.71 derived: net income ÷ weighted average shares · filed 2015-08-10 | ||||||
| 2013-06-30 | $0.01 10-Q · filed 2013-08-08 | -$0.10 10-Q · filed 2013-08-08 | ||||||
| 2012-06-30 | -$0.18 10-Q · filed 2013-08-08 | -$0.37 10-Q · filed 2013-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |